How Can We Expect Today's Science Grads To Remain `Immersed, Active, And Hopeful'?

In this issue, we pay special attention to the thousands of young men and women across the United States who have just received their degrees in science and are about to step into the next phase of developing their careers. The Scientist congratulates all of them and wishes them well. For those who elect to persist in their scientific pursuits, the road ahead, judging from a number of indicators, is likely to be bumpy; their path toward intellectual, creative, and professional fulfillment isn'

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Scientist congratulates all of them and wishes them well. For those who elect to persist in their scientific pursuits, the road ahead, judging from a number of indicators, is likely to be bumpy; their path toward intellectual, creative, and professional fulfillment isn't going to be an easy one.

Why, indeed, should a young man or woman choose to forge ahead in a science career today rather than pursue, say, investment banking, real estate, or advertising? Issue after issue of this publication reports on the crisis in research funding; competition for jobs in many disciplines seems to be heating up; and although salaries in several scientific fields are on the rise (see story on page 1), few positions pay well enough for money to be the central attraction.

Compounding these problems is the presence of several troublesome, more abstract, sources of discouragement: How can a young man or woman get ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies